Researcher
Alex Michotte
- Keywords:Medicine
- Disciplines:Neurological and neuromuscular diseases
Affiliations
- Neuroprotection & Neuromodulation (Research group)
Member
From1 Oct 2008 → Today - Pathology (Department)
Member
From1 Jan 2008 → Today - Neurology (Department)
Member
From1 Jan 2008 → Today - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → 30 Sep 2023 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Anatomy (Department)
Member
From1 Oct 2005 → 31 Dec 2013
Publications
31 - 40 of 40
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma;(2009)
Authors: Bart Neyns, Jan Sadones, Eric Joosens, F Bouttens, L Verbeke, Jean-François Baurain, L Dhondt, T Strauven, C. Chaskis, Pieter in 't Veld, et al.
Pages: 1596-1603 - Fatal Intracerebral Haemorrhage Following Carotid Endarterectomy in a Patient with Cerebral Amyloid Angiopathy(2009)
Authors: Sofie Willems, Erik Debing, Alex Michotte, Cristo Chaskis, Pierre Van Den Brande
Pages: 245-247 - PSEUDOPROGRESSION AFTER RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE FOR HIGH-GRADE GLIOMA: CLINICAL OBSERVATIONS AND WORKING RECOMMENDATIONS.(2009)
Authors: C. Chaskis, Bart Neyns, Alex Michotte, Mark De Ridder, Hendrik Everaert
Pages: 423-428 - MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma(2009)
Authors: Jan Sadones, Alex Michotte, Pieter in 't Veld, C. Chaskis, R. Sciot, J Menten, E.j.r. Joossens, T Strauven, L.a. D'hondt, D. Sartenaer, et al.
Pages: 146-153 - Modification of hormonal secretion in clinically silent pituitary adenomas.(2009)
Authors: Tania Daems, J. Verhelst, Alex Michotte, Pascale Abrams, Dirk De Ridder, R. Abs
Pages: 80-86 - A MULTICENTER STRATIFIED PHASE II STUDY OF CETUXIMAB FOR THE TREATMENT OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA(2008)
Authors: Bart Neyns, Jan Sadones, E.j.r. Joossens, F Bouttens, L Verbeke, J. Baurain, Lionel D'hondt, T Strauven, C. Chaskis, Alex Michotte
Pages: 1067-1067 - EVALUATION OF THE EARLY ANTIANGIOGENIC ACTIVITY OF SUNITINIB MALATE BY PERFUSION CBF AND CBV VALUES FROM DSC-BASED PERFUSION IN RECURRENT GLIOBLASTOMA(2008)
Authors: C. Chaskis, Martine Dujardin, Alex Michotte, Bart Neyns
Pages: 1062-1062 - Management of diffuse glioma in children: a retrospective study of 27 cases and review of literature.(2008)
Authors: Caroline Piette, Manuel Deprez, Jacques Born, Alex Michotte, C. Munaut, Marie-Thérèse Closon, Isabelle Rutten, Marie-Françoise Dresse, Patricia Forget, Veronique Schmitz, et al.
Pages: 35-43 - PRIMARY LEPTOMENINGEAL ANAPLASTIC OLIGODENDROGLIOMA WITH A 1P36-19Q13 DELETION: REPORT OF A UNIQUE CASE SUCCESSFULLY TREATED WITH TEMOZOLOMIDE(2008)
Authors: Alex Michotte, C. Chaskis, Bart Neyns, A. Tyberghien, M Declerck, Ines Origer, Jan Sadones, Pieter in 't Veld
Pages: 1087-1088 - A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma(2008)
Authors: Bart Neyns, C. Chaskis, Eric Joosens, Johan Menten, Lionel D'hondt, Fabrice Branle, Jan Sadones, Alex Michotte
Pages: 269-277